Applications of flow cytometry to clinical microbiology

• Published in: Clinical microbiology reviews 2000-04, Vol.13 (2), p.167-195
• Main Authors: ALVAREZ-BARRIENTOS, A, ARROYO, J, CANTON, R, NOMBELA, C, SANCHEZ-PEREZ, M
• Format: Article
• Language: English
• Subjects: Bacteriology; Biological and medical sciences; Flow Cytometry - instrumentation; Flow Cytometry - methods; Fundamental and applied biological sciences. Psychology; Humans; Infection - diagnosis; Infection - drug therapy; Infection - microbiology; Laboratories; Microbial Sensitivity Tests; Microbiological Techniques - instrumentation; Microbiology; Motility, taxis
• ISSN: 0893-8512; 1098-6618
• DOI: 10.1128/cmr.13.2.167

Classical microbiology techniques are relatively slow in comparison to other analytical techniques, in many cases due to the need to culture the microorganisms. Furthermore, classical approaches are difficult with unculturable microorganisms. More recently, the emergence of molecular biology techniques, particularly those on antibodies and nucleic acid probes combined with amplification techniques, has provided speediness and specificity to microbiological diagnosis. Flow cytometry (FCM) allows single- or multiple-microbe detection in clinical samples in an easy, reliable, and fast way. Microbes can be identified on the basis of their peculiar cytometric parameters or by means of certain fluorochromes that can be used either independently or bound to specific antibodies or oligonucleotides. FCM has permitted the development of quantitative procedures to assess antimicrobial susceptibility and drug cytotoxicity in a rapid, accurate, and highly reproducible way. Furthermore, this technique allows the monitoring of in vitro antimicrobial activity and of antimicrobial treatments ex vivo. The most outstanding contribution of FCM is the possibility of detecting the presence of heterogeneous populations with different responses to antimicrobial treatments. Despite these advantages, the application of FCM in clinical microbiology is not yet widespread, probably due to the lack of access to flow cytometers or the lack of knowledge about the potential of this technique. One of the goals of this review is to attempt to mitigate this latter circumstance. We are convinced that in the near future, the availability of commercial kits should increase the use of this technique in the clinical microbiology laboratory.